Capecitabine/irinotecan combination regimens in colorectal cancer.

Capecitabine/irinotecan combination regimens in colorectal cancer.

Capecitabine (Xeloda) and irinotecan (CPT-11, Camptosar) both have demonstrated single-agent activity in patients with colorectal cancer. In an analysis of pooled results of two phase III studies, capecitabine provided advantages over intravenous fluorouracil (5-FU) plus leucovorin in patients with...

Deskribapen osoa

Xehetasun bibliografikoak
Egile nagusia:	Kerr, D
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2002

Antzeko izenburuak

Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials.
nork: Kerr, D
Argitaratua: (2002)

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer
nork: Pui Lam Yip, et al.
Argitaratua: (2023-04-01)

Capecitabine/irinotecan in coloreetal cancer: European early-phase data and planned trials
nork: Kerr, D
Argitaratua: (2002)

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.
nork: Rea, D, et al.
Argitaratua: (2005)

The effective combination therapies with irinotecan for colorectal cancer
nork: Yun Chai, et al.
Argitaratua: (2024-02-01)

Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment.
nork: Kerr, D
Argitaratua: (2008)

Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer
nork: N. V. Dobrova, et al.
Argitaratua: (2019-12-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
nork: Maria Ignez Freitas Melro Braghiroli, et al.
Argitaratua: (2024-01-01)

Triple combination of irinotecan + oxaliplatin + 5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer: first experience with a new treatment regimen
nork: A. D. Darenskaya, et al.
Argitaratua: (2018-05-01)

Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer
nork: N. V. Dobrova, et al.
Argitaratua: (2018-11-01)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
nork: Chu Matsuda, et al.
Argitaratua: (2023-01-01)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
nork: Kerr, R, et al.
Argitaratua: (2016)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
nork: Love, S, et al.
Argitaratua: (2016)

FTORAFUR IN COMBINATION WITH OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH DISSEMINATED COLORECTAL CANCER: PRELIMINARY RESULTS
nork: N. V. Dobrova, et al.
Argitaratua: (2018-02-01)

Dietary silymarin supplementation enhances chemotherapy efficacy of capecitabine and irinotecan and mitigates hepatotoxicity in a mouse model of colon cancer
nork: Sepideh Hassani, et al.
Argitaratua: (2025-01-01)

Irinotecan in the treatment of colorectal cancer. A literature review
nork: V. A. Ivanov, et al.
Argitaratua: (2017-04-01)

Effect of Tarantula cubensis alcohol extract and Capecitabin combine in Colorectal Cancer rats
nork: Rahmi Canbar, et al.
Argitaratua: (2023-06-01)

The Effect of Captopril Added to Standard Chemotherapy Regimen Containing Capecitabine in the Prevention of Hand and Foot Syndrome in Patients with Colorectal Cancer
nork: Mahnaz Roayaei, et al.
Argitaratua: (2019-10-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
nork: Wachsberger, P, et al.
Argitaratua: (2009)

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
nork: Satoru Iwasa, et al.
Argitaratua: (2023-04-01)

High‐Load Core@Shell Nanocarriers with Irinotecan and 5‐Fluorouracil for Combination Chemotherapy in Colorectal Cancer
nork: Silke Notter, et al.
Argitaratua: (2024-11-01)

Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
nork: Moe, M, et al.
Argitaratua: (2008)

Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells
nork: Christian Marx, et al.
Argitaratua: (2021-12-01)

An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer
nork: Hongyan Zhou, et al.
Argitaratua: (2024-07-01)

Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer
nork: Rulei Yang, et al.
Argitaratua: (2024-04-01)

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer.
nork: Sabharwal, A, et al.
Argitaratua: (2010)

Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer
nork: Mashiro Okunaka, et al.
Argitaratua: (2021-04-01)

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
nork: Jinwei Zhu, et al.
Argitaratua: (2023-09-01)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
nork: Middleton, G, et al.
Argitaratua: (2013)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).
nork: Middleton, G, et al.
Argitaratua: (2013)

044. Unlocking The Potential: Comparing The Effects of Probiotics Alone and in Combination with Capecitabine Against Colorectal Cancer in Rats
nork: Reza Yuneri Putri, et al.
Argitaratua: (2024-11-01)

Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
nork: Tianqun Lang, et al.
Argitaratua: (2023-08-01)

Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients
nork: Sara Shamseldin, et al.
Argitaratua: (2023-10-01)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
nork: Lakshmi Chintala, et al.
Argitaratua: (2011-06-01)

Oxyresveratrol Alleviates Irinotecan-Induced Diarrhea and Enhances Antitumor Effects in Colorectal Cancer
nork: Yang X, et al.
Argitaratua: (2024-12-01)

Increased response of oxaliplatin or irinotecan on chemosensitivity to 5-fluorouracil in patients with colorectal cancer
nork: Se Na Cho, et al.
Argitaratua: (2014-06-01)

Integrated Bioinformatics Analysis of the Hub Genes Involved in Irinotecan Resistance in Colorectal Cancer
nork: Jakub Kryczka, et al.
Argitaratua: (2022-07-01)

Capecitabine: have we got the dose right?
nork: Midgley, R, et al.
Argitaratua: (2009)

Capecitabine: Have we got the dose right?
nork: Midgley, R, et al.
Argitaratua: (2009)

Capecitabine: Have we got the dose right?
nork: Midgley, R, et al.
Argitaratua: (2009)